Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21 | 146 | 737 | 953 | 130 |
| Marketable Securities | N/A | N/A | 1,053 | 565 | 680 |
| Receivables | 23 | 3 | 15 | 5 | 3 |
| Other current assets | 0 | 0 | 0 | 12 | 10 |
| TOTAL | $262 | $156 | $1,921 | $1,536 | $823 |
| Non-Current Assets | |||||
| Intangibles | 261 | 256 | 281 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 136 | 0 | 0 |
| TOTAL | $261 | $256 | $417 | $N/A | $0 |
| Total Assets | $522 | $413 | $2,338 | $1,537 | $825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 299 | 1,147 | 0 | 0 |
| Accounts payable and accrued liabilities | 3,714 | 753 | 224 | 360 | 50 |
| Other current liabilities | N/A | N/A | 0 | 480 | 0 |
| TOTAL | $3,964 | $1,052 | $1,371 | $832 | $48 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 156 | 0 | 0 | 0 | 0 |
| TOTAL | $156 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $4,120 | $1,052 | $1,371 | $832 | $48 |
| Shareholders' Equity | |||||
| Common Shares | 12,264 | 10,312 | 8,021 | 4,980 | 3,390 |
| Retained earnings | -18,170 | -13,688 | -9,966 | -6,279 | -4,218 |
| Other shareholders' equity | 2,308 | 2,737 | 2,912 | 2,003 | 1,605 |
| TOTAL | $-3,597 | $-639 | $967 | $705 | $777 |
| Total Liabilities And Equity | $522 | $413 | $2,338 | $1,537 | $825 |